| Issue |
Section |
Title |
File |
| Vol 10, No 1 (2014) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
THE HPV STATUS IN BLADDER CANCER, TUMOR MORPHOLOGICAL CHARACTERISTICS, AND CLINICAL FEATURES OF THE DISEASE |
(Rus)
|
| Vol 6, No 1 (2010) |
PROSTATE CANCER |
PROGNOSTIC VALUE OF MICROVASCULAR AND PERINEURAL INVASION IN PATIENTS WITH PROSTATE CANCER PT1-4N0-1M0 WHO UNDERWENT RADICAL PROSTATECTOMY |
(Rus)
|
| Vol 6, No 1 (2010) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. TESTICULAR CANCER |
RETROPERITONEAL LYMPH NODE DISSECTION AFTER INDUCTION CHEMOTHERAPY IN METASTATIC TESTICULAR NON-SEMINOMA |
(Rus)
|
| Vol 10, No 1 (2014) |
REVIEW |
ANDROGEN DEPRIVATION THERAPY WITH LUTEINIZING HORMONE-RELEASING HORMONE ANTAGONISTS FOR PROSTATE CANCER: BEST DISEASE CONTROL WITH A LOWER RISK OF SIDE EFFECTS. RESULTS OF ANALYSIS OF 6 COMPARATIVE RANDOMIZED PHASE III TRIALS OF DEGARELIX AND LUTEINIZIN |
(Rus)
|
| Vol 7, No 1 (2011) |
LECTURE |
TREATMENT FOR STAGE I NONSEMINOMATOUS TESTICULAR GERM CELL TUMORS |
(Rus)
|
| Vol 10, No 2 (2014) |
CLINICAL CASE |
DIAGNOSIS OF KIDNEY TUMOR AND NON-ORGAN RETROPERITONEAL LIPOSARCOMA |
(Rus)
|
| Vol 7, No 1 (2011) |
PROSTATE CANCER |
COMPARATIVE ANALYSIS OF THE RESULTS OF CONTINUOUS AND INTERMITTENT HORMONE THERAPY FOR DISSEMINATED PROSTATE CANCER |
(Rus)
|
| Vol 7, No 1 (2011) |
PROSTATE CANCER |
ROLE OF DEGARELIX (FIRMAGON) IN THE TREATMENT OF DISSEMINATED PROSTATE CANCER: CAN THE QUALITY OF CASTRATION THERAPY BE IMPROVED? |
(Rus)
|
| Vol 7, No 1 (2011) |
CLINICAL CASE |
SINGLE LEFT KIDNEY RE-RESECTION PERFORMED 5 YEARS AFTER EXTRACORPOREAL RESECTION: A CLINICAL OBSERVATION |
(Rus)
|
| Vol 9, No 4 (2013) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
THE SAFETY AND EXPEDIENCY OF USING A TRANSPERITONEAL LAPAROSCOPIC ACCESS TO RADICAL NEPHRECTOMY FOR CLINICALLY LOCALIZED KIDNEY CANCER |
(Rus)
|
| Vol 9, No 1 (2013) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
SEQUENTIAL TARGETED THERAPY FOR DISSEMINATED KIDNEY CANCER |
(Rus)
|
| Vol 9, No 4 (2013) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. TESTICULAR CANCER |
BRAIN METASTASES OF GERM CELL TUMORS. THE RUSSIAN CANCER RESEARCH CENTER'S EXPERIENCE |
(Rus)
|
| Vol 9, No 4 (2013) |
REVIEW |
PERI-OPERATIVE CHEMOTHERAPY IN MUSCLE INVASIVE BLADDER CANCER: OVERVIEW AND A RATIONALE FOR THE NEED TO SEEK ALTERNATIVE TREATMENT: MAGNOLIA CLINICAL TRIAL |
(Rus)
|
| Vol 7, No 2 (2011) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
UPPER URINARY TRACT TUMORS: 23-YEAR EXPERIENCE OF A CLINIC |
(Rus)
|
| Vol 6, No 2 (2010) |
REVIEW |
CURRENT TREATMENTS FOR UROTHELIAL CANCER OF THE UPPER URINARY TRACT |
(Rus)
|
| Vol 7, No 2 (2011) |
PROSTATE CANCER |
BEAM THERAPY AND LONG-TERM HORMONAL THERAPY IN PATIENTS WITH PROSTATE CANCER |
(Rus)
|
| Vol 7, No 2 (2011) |
PROSTATE CANCER |
PREDICTORS OF SURVIVAL IN DISSEMINATED PROSTATE CANCER PATIENTS RECEIVING HORMONAL THERAPY |
(Rus)
|
| Vol 7, No 2 (2011) |
CLINICAL CASE |
NEUROENDOCRINE CARCINOMA OF THE PROSTATE: A CASE REPORT |
(Rus)
|
| Vol 7, No 4 (2011) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
PROGNOSTIC VALUE OF MOLECULAR GENETIC MARKERS IN KIDNEY CANCER PATIENTS RECEIVING TARGETED THERAPY |
(Rus)
|
| Vol 9, No 1 (2013) |
CLINICAL CASE |
PROSTATIC STROMAL TUMOR: A CASE IN A 22-YEAR-OLD PATIENT |
(Rus)
|
| Vol 7, No 4 (2011) |
REVIEW |
POSSIBILITIES OF USING THE FLUORESCENCE IN SITU HYBRIDIZATION TECHNIQUE IN THE DIAGNOSIS OF BLADDER CANCER AND ITS RECURRENCES |
(Rus)
|
| Vol 7, No 3 (2011) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
LOCAL RECURRENCE OF TUBULOCYSTIC CARCINOMA 4 YEARS AFTER RENAL RESECTION (A CLINICAL OBSERVATION) |
(Rus)
|
| Vol 7, No 3 (2011) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
HUMAN PLASMA PROTEOME MAPPING IN HEALTH AND CLEAR CELL CARCINOMA OF THE KIDNEY |
(Rus)
|
| Vol 7, No 3 (2011) |
CLINICAL CASE |
LOCAL RECURRENCE OF TUBULOCYSTIC CARCINOMA 4 YEARS AFTER RENAL RESECTION (A CLINICAL OBSERVATION) |
(Rus)
|
| Vol 7, No 3 (2011) |
CLINICAL CASE |
GIANT RENAL ANGIOMYOLIPOMAS AS A MANIFESTATION OF BOURNEVILLE-PRINGLE DISEASE |
(Rus)
|
| Vol 5, No 2 (2009) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS |
SMALL-DOSE CYTOKINES IN COMBINATION WITH 5-FLUOROURACIL IN OLISSEMINATED RENAL CELL CARCINOMA: FINAL RESULTS OF A RANDOMIZED TRIAL |
(Rus)
|
| Vol 5, No 4 (2009) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS |
GEMCYTABIN (CYTOGEM®) AND CISPLATIN AS FIRST-LINE THERAPY FOR ADVANCED BLADDER CANCER: RESULTS OF A PROSPECTIVE OPEN-LABELED NON-COMPARATIVE NON-RANDOMIZED STUDY |
(Rus)
|
| Vol 8, No 2 (2012) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
IMPACT OF SECONDARY TRANSURETHRAL RESECTION ON RECURRENCE RATES IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER |
(Rus)
|
| Vol 8, No 4 (2012) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
IMPACT OF REPEAT TRANSURETHRAL RESECTION ON TREATMENT RESULTS IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER |
(Rus)
|
| Vol 6, No 4 (2010) |
PROSTATE CANCER |
CHEMOTHERAPY FOR HORMONE REFRACTORY PROSTATE CANCER |
(Rus)
|
| Vol 6, No 4 (2010) |
PROSTATE CANCER |
RUSSIAN EXPERIENCE WITH TAXOTERE USED IN THERAPY FOR METASTATIC HORMONE REFRACTORY PROSTATE CANCER: RESULTS OF THE DESCRIPTIVE TANDEM STUDYA |
(Rus)
|
| Vol 6, No 4 (2010) |
PROSTATE CANCER |
SURGICAL REHABILITATION IN PATIENTS WITH ERECTILE DYSFUNCTION AFTER RADICAL PROSTATECTOMY OR CYSTECTOMY |
(Rus)
|
| Vol 8, No 4 (2012) |
PROSTATE CANCER |
PROGNOSTIC FACTORS OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY FOR LOCALIZED AND LOCALLY-ADVANCED PROSTATE CANCER |
(Rus)
|
| Vol 6, No 4 (2010) |
PROSTATE CANCER |
LEUPRORELIN ACETATE DEPOT (ELIGARD) IN THE TREATMENT OF PROSTATE CANCER: WHAT DO PATIENTS WIN? |
(Rus)
|
| Vol 6, No 4 (2010) |
CLINICAL CASE |
METASTASIS OF RENAL CARCINOMA TO THE THYROID, SPECIFIC FEATURES OF DIAGNOSIS AND TREATMENT (DESCRIPTION OF A CASE) |
(Rus)
|
| Vol 6, No 4 (2010) |
CLINICAL CASE |
HUMAN PAPILLOMAVIRUS AS A RISK FACTOR FOR BLADDER CANCER |
(Rus)
|
| Vol 10, No 3 (2014) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Impact of surgical volume on functional results and cardiospecific survival rates in patients with clinically localized renal cancer |
(Rus)
|
| Vol 10, No 3 (2014) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Predictors of the immediate results of thrombectomy in kidney cancer patients with venous tumor thrombosis |
(Rus)
|
| Vol 10, No 4 (2014) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Kidney re-resections 5 years after extracorporeal resections |
(Rus)
|
| Vol 11, No 1 (2015) |
REVIEW |
Noninterventional studies of depot formulations of LHRH analogues for prostate cancer in routine clinical practice. The launch of an observational program to assess the use of Eligard 45 mg in Russia |
(Rus)
|
| Vol 11, No 1 (2015) |
REVIEW |
Sorafenib is the first targeted agent to treat metastatic kidney cancer |
(Rus)
|
| Vol 11, No 2 (2015) |
PROSTATE CANCER |
Dual-stage 18F-fluorocholine PET/CT scanning for biochemical recurrences of prostate cancer |
(Rus)
|
| Vol 11, No 2 (2015) |
PROSTATE CANCER |
Predictors of overall survival in patients with metastatic castration-resistant prostate cancer |
(Rus)
(Eng)
|
| Vol 11, No 3 (2015) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS |
Palliative nephrectomy until targeted therapy of disseminated kidney cancer patients |
(Rus)
|
| Vol 11, No 3 (2015) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS |
Radiodiagnostic methods in determining the structure of tumor thrombus in the inferior vena cava in kidney cancer |
(Rus)
|
| Vol 11, No 4 (2015) |
CLINICAL CASE |
Squamous cell carcinoma of the seminal vesicle. Review of the related literature and case report |
(Rus)
|
| Vol 12, No 2 (2016) |
PROSTATE CANCER |
Intermediate results of the observational program on the Eligard (45 mg) administration in the clinical practice |
(Rus)
(Eng)
|
| Vol 12, No 4 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Molecular genetic diagnostics of clear cell renal cell carcinoma |
(Rus)
|
| Vol 12, No 3 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
The efficacy and safety of vinflunine in second-line therapy of patients with disseminated transitional cell carcinoma of the urinary tract in clinical practice |
(Rus)
(Eng)
|
| Vol 12, No 3 (2016) |
CONGRESSES AND CONFERENCES |
Resolution on the results of the Meeting of Experts on the treatment of castrate-resistant prostate cancer |
(Rus)
|
| Vol 12, No 4 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Surgical treatment of Renal Cell Carcinoma (RCC) with level III–IV tumor venous thrombosis |
(Rus)
|
| Vol 13, No 1 (2017) |
REVIEW |
Role and significance of multiparametric magnetic resonance imaging in prostate cancer diagnostics |
(Rus)
|
| Vol 13, No 1 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Surgical treatment of renal cell carcinoma with advanced tumor invasion of the inferior vena cava |
(Rus)
|
| Vol 13, No 3 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Functional results of partial nephrectomy in solitary functioning kidney tumors |
(Rus)
|
| Vol 13, No 2 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Partial nephrectomy for patients with a solitary kidney |
(Rus)
|
| Vol 13, No 2 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Final results of the prospective multicenter observational program RU-EGD-NI-001 for evaluation of efficacy and tolerability of the 6-month depot Eligard 45 mg in patients with advanced prostate carcinoma in routine clinical practice of uro-oncologists in the Russian Federation |
(Rus)
|
| Vol 13, No 3 (2017) |
PROSTATE CANCER |
The use of MRI/ultrasound fusion biopsy in the diagnosis of clinically significant prostate cancer |
(Rus)
|
| Vol 14, No 1 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Nephrectomy, inferior vena cava thrombectomy in renal cell carcinoma with tumor venous thrombosis and pulmonary metastases |
(Rus)
|
| Vol 13, No 3 (2017) |
LECTURE |
Nivolumab as the new standard of metastatic kidney cancer treatment |
(Rus)
|
| Vol 13, No 3 (2017) |
REVIEW |
Possibilities of optimization of the second line targeted therapy for metastatic renal cell carcinoma |
(Rus)
|
| Vol 13, No 3 (2017) |
REVIEW |
Radium-223 in treatment of castration-resistant prostate cancer with skeletal metastases |
(Rus)
|
| Vol 13, No 3 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
Vinflunine as second-line therapy for advanced urothelial carcinoma: Russian observational study |
(Rus)
|
| Vol 14, No 1 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Salvage radiotherapy of prostate cancer recurrences after radical prostatectomy |
(Rus)
|
| Vol 14, No 1 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Clinical features and results of surgical treatment of bilateral renal cancer |
(Rus)
|
| Vol 13, No 4 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Polymerase chain reaction assay for the detection of human papillomavirus type 16 genetic material in the intraoperative material from patients with prostate cancer |
(Rus)
|
| Vol 13, No 4 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Evaluation of safety and advisability of salvage lymph node dissection in patients with lymphogenic metastases of prostate cancer after radical treatment |
(Rus)
|
| Vol 13, No 4 (2017) |
CLINICAL CASE |
Description of a clinical case of synchronous cancer in the native and graft kidneys |
(Rus)
|
| Vol 13, No 4 (2017) |
CONGRESSES AND CONFERENCES |
Review of the Proceedings of the European Society for Medical Oncology (ESMO) 2017 Congress |
(Rus)
|
| Vol 14, No 1 (2018) |
REVIEW |
On staging of urologic cancers in accordance with the updated 8th edition of the TNM Classification |
(Rus)
|
| Vol 14, No 2 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Modern approaches to kidney cancer immunotherapy |
(Rus)
|
| Vol 14, No 1 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Lenvatinib in combination with everolimus in metastatic renal cell carcinoma resistant to antiangiogenic targeted therapy: an initial Russian experience |
(Rus)
|
| Vol 14, No 1 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Safety of enzalutamide in patients with progressive castration-resistant prostate cancer previously treated with docetaxel-based chemotherapy: a phase II, multicenter, single-arm, open-label study |
(Rus)
|
| Vol 14, No 4 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
Small-cell bladder cancer: literature review |
(Rus)
|
| Vol 14, No 2 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Resection of the inferior vena cava in patients with renal cell carcinoma with bulky tumor venous thrombosis |
(Rus)
|
| Vol 14, No 3 (2018) |
CLINICAL CASE |
18F-PSMA-1007 POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY IN THE DIAGNOSIS OF RECURRENT PROSTATE CANCER: CLINICAL OBSERVATION |
(Rus)
|
| Vol 14, No 2 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Risk-adapted approach to prostate cancer screening |
(Rus)
(Eng)
|
| Vol 14, No 3 (2018) |
REVIEW |
MOLECULAR EPIDEMIOLOGY OF RENAL CANCER |
(Rus)
|
| Vol 14, No 3 (2018) |
CONGRESSES AND CONFERENCES |
REVIEW OF THE ONCOLOGICAL UROLOGY PROCEEDINGS OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) 2018 ANNUAL MEETING |
(Rus)
|
| Vol 15, No 1 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Soluble forms of the immune check-point receptor PD-1 and its ligand PD-L1 in blood serum of patients with renal cell carcinoma: clinical and pathologic correlations |
(Rus)
|
| Vol 14, No 4 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Safety of left renal vein ligation during circular resection of the inferior vena cava in right-side kidney carcinoma with tumor venous thrombosis |
(Rus)
|
| Vol 14, No 3 (2018) |
REVIEW |
SEQUENTIAL THERAPY OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: NEW POSSIBILITIES |
(Rus)
|
| Vol 14, No 4 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
A joint determination of gene expression and methylation for the diagnosis of clear cell renal cancer |
(Rus)
|
| Vol 15, No 1 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
The first experience of using obturator nerve block to prevent spasm of adductor muscles of the thigh during transurethral resection of bladder |
(Rus)
|
| Vol 14, No 4 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Impact of germline CHEK2 mutations on biochemical relapse free survival and metastasis free survival after radical treatment for patients with prostate cancer |
(Rus)
|
| Vol 15, No 1 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Prognostic role of PBRM1 marker expression in clear-cell renal-cell carcinoma |
(Rus)
|
| Vol 14, No 4 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Renal cell carcinoma: What’s new in 2018 |
(Rus)
|
| Vol 15, No 2 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Prostate-specific antigen is a predictor of the efficacy of salvage radiation therapy in patients with recurrent prostate cancer after radical prostatectomy |
(Rus)
|
| Vol 15, No 1 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
The prognostic value of tumor PD-L1 status in patients with metastatic prostate cancer |
(Rus)
|
| Vol 15, No 1 (2019) |
REVIEW |
Changing paradigm of immunooncology in advanced kidney cancer: nivolumab and ipilimumab combination in the first line therapy |
(Rus)
|
| Vol 15, No 3 (2019) |
CLINICAL CASE |
Clinical case of lymphoma of the seminal vesicle |
(Rus)
|
| Vol 15, No 3 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
18F-PSMA-1007 and 18F-fluorocholine PET/CT in prostate cancer progression diagnostics. First comparative experience |
(Rus)
|
| Vol 15, No 4 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Is technically complicated partial nephrectomy justified in renal cell carcinoma patients with normal contralateral kidney? |
(Rus)
|
| Vol 15, No 4 (2019) |
LECTURE |
Current advances in kidney cancer immunotherapy |
(Rus)
|
| Vol 16, No 1 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Expression of growth factors and tyrosine kinase receptors in the primary tumor and tumor thrombus cells in patients with renal cell carcinoma |
(Rus)
|
| Vol 4, No 1 (2008) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Outcome analysis of treatment of local recurrences of renal cell carcinoma |
(Rus)
|
| Vol 4, No 1 (2008) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
European Association of Urology Guidelines for the Management of Renal Cancer |
(Rus)
|
| Vol 3, No 4 (2007) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Prognostic value of expression of thymidine phosphorylase, Bcl-2, and Ki-67 in renal cancer T1-2N0M0 |
(Rus)
|
| Vol 3, No 4 (2007) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
Treatment and prognosis in patients with transitional cell carcinoma of the urinary bladder metastasizing to regional lymph nodes |
(Rus)
|
| Vol 2, No 4 (2006) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Small-dose cytokines and their combination with 5-fluorouracil for disseminated renal-cell carcinoma. Preliminary results of randomized trial |
(Rus)
|
| Vol 1, No 2 (2005) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS |
Surgical management of Renal Cell Carcinoma with tumor thrombosis of renal vein and inferior vena cava |
(Rus)
|
| Vol 3, No 2 (2007) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Contemporary roll of organ-preserving surgery of renal cell carcinoma |
(Rus)
|
| Vol 2, No 1 (2006) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Do We Treat Prostatic Cancer Correctly? |
(Rus)
|
| Vol 3, No 2 (2007) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Zometa in therapy for bone metastases of prostate cancer during androgenic deprivation (Results of Russian multicenter study) |
(Rus)
|
| Vol 16, No 1 (2020) |
LECTURE |
Radium chloride [223Ra] for patients with prostate cancer and skeletal metastases. Clinical recommendations |
(Rus)
|
| Vol 16, No 1 (2020) |
TOPICAL PROBLEM |
Potential algorithm of prostate cancer management during the pandemic of coronavirus infection (COVID-19) |
(Rus)
|
| Vol 16, No 3 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Radiotherapy for patients with locoregional and oligometastatic relapses of prostate cancer after radical prostatectomy |
(Rus)
|
| Vol 16, No 4 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Methylation of a group of microRNA genes: markers of renal cell carcinoma metastasis |
(Rus)
|
| Vol 16, No 3 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Non-interventional study of treatment approaches in patients with locally advanced prostate cancer who have undergone prostatectomy or radiation therapy (PREVENT) |
(Rus)
|
| Vol 16, No 3 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
An interim analysis of non-interventional study of the epidemiology and natural history of non-metastatic castration-resistant prostate cancer in Russia |
(Rus)
|
| Vol 16, No 4 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Clinical implication of kidney injury molecule (KIM-1) in blood plasma of renal-cell cancer patients |
(Rus)
|
| Vol 17, No 1 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Nephrectomy and thrombectomy in renal cell carcinoma patients with extensive tumor venous thrombosis: how to minimize surgical risks? |
(Rus)
|
| Vol 16, No 4 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Efficacy and safety of radium-223 in routine clinical practice |
(Rus)
|
| Vol 16, No 4 (2020) |
REVIEW |
International experience of using olaparib for metastatic castration-resistant prostate cancer: literature review |
(Rus)
|
| Vol 17, No 2 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Technique and short-term outcomes of surgical treatment in patients with renal cell carcinoma and tumor venous thrombosis: experience of the Urology Clinic, N.N. Blokhin National Medical Research Center of Oncology |
(Rus)
|
| Vol 17, No 3 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Prognosis of patients operated on for renal cell carcinoma and tumor venous thrombosis: experience of the Urology Clinics, N.N. Blokhin National Medical Research Center of Oncology |
(Rus)
|
| Vol 17, No 1 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Efficacy and safety of lenvatinib and everolimus combination in patients with metastatic renal cell carcinoma progression following targeted antiangiogenic therapy: secondary analysis of data obtained in the Russian multicenter observational study |
(Rus)
|
| Vol 17, No 2 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Luteinizing hormone-releasing hormone agonists for prostate cancer patients: routine clinical practice of Russian cancer urologists |
(Rus)
|
| Vol 18, No 1 (2022) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. TESTICULAR CANCER |
Structure of residual metastases in patients with advanced testicular non-seminomatous germ cell tumors and incomplete serological and radiological response to chemotherapy |
(Rus)
|
| Vol 17, No 4 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Similarities and differences in the process of metastasis and differentiation of renal cancer on gene expression |
(Rus)
|
| Vol 18, No 2 (2022) |
REVIEWS |
Viral infections in prostate carcinogenesis: literature review |
(Rus)
|
| Vol 18, No 2 (2022) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Prognostic significance of sPD-1/sPD-L1 in renal cancer depending on the phenotype of tumor and stromal cells |
(Rus)
|
| Vol 18, No 2 (2022) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Epidemiology and natural history of non-metastatic castration-resistant prostate cancer in Russia |
(Rus)
|
| Vol 18, No 4 (2022) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Study of the action of peripheral blood T-lymphocytes on renal cell carcinoma cells in model systems |
(Rus)
|
| Vol 19, No 4 (2023) |
CLINICAL CASE |
Organ-preserving surgical treatment of a patient with synchronous bilateral morphologically different renal cell carcinoma, inferior vena cava tumor thrombus and pyeloureteral segment stone: clinical case |
(Rus)
|
| Vol 19, No 1 (2023) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Efficacy and safety of cabozantinib in metastatic renal cell carcinoma patients: Russian multicenter observational study |
(Rus)
|
| Vol 19, No 4 (2023) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Functional outcomes of repeat kidney resection in patients with cancer recurrence after nephron-sparing surgeries |
(Rus)
|
| Vol 19, No 4 (2023) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Metastasis suppressor kisspeptin (KISS1) in serum of patients with renal cell carcinoma |
(Rus)
|
| Vol 20, No 2 (2024) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Salvage radiation therapy after radical prostatectomy: long-term results of a prospective study |
(Rus)
|
| Vol 20, No 2 (2024) |
CLINICAL NOTES |
Solitary fibrous tumor of the prostate: clinical case and literature review |
(Rus)
|
| Vol 21, No 2 (2025) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. TESTICULAR CANCER |
Search for new microRNAs for differential diagnosis of teratomas |
(Rus)
|
| Vol 21, No 1 (2025) |
REVIEW |
Aspects of hypogonadism in oncological patients receiving antitumor treatment. Literature review |
(Rus)
|
| Vol 21, No 2 (2025) |
CLINICAL NOTES |
Combination of lenvatinib and pembrolizumab in treatment of patients with metastatic renal cell carcinoma and factors of poor prognosis |
(Rus)
|
| Vol 21, No 4 (2025) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
dd-MVAC as neoadjuvant chemotherapy for muscle-invasive bladder cancer: a single-center study |
(Rus)
|
